DS0304 - Chimie Durable, produits, procédés associés

Recombinant Elastin-like Polypeptides as Precision Polymer Scaffolds towards Synthetic Glycoconjugates – ELP

Submission summary

There are relevant opportunities to develop innovative synthetic strategies at the frontier between biotechnology and traditional organic chemistry to produce polymers fulfilling requirements of sustainability and precision, towards the development of functional, high value-added, polymer materials such as those used in the biomedical field.
The present research project proposes the use of protein-engineering techniques to access functional precision polymer scaffolds with exquisite control over monomer sequence and length, namely with an exact “primary structure”. Orthogonal bioconjugation strategies will then be applied to chemoselectively modify specific residues of the recombinant polypeptides so as to introduce biologically relevant motifs, as a means to access well-defined and high molecular weight multivalent bioconjugates.
As a proof of concept, the project will be applied to the synthesis of chemical tools for glycobiology, where there is a critical need for the rational design of glycoprotein mimics for drug-targeting and vaccination strategies. Recombinant elastin-like polypeptide (ELP) scaffolds will therefore be glycosylated with specific carbohydrates and different grafting densities to address major questions in multivalent glyconjugates’ design.

Project coordination

Elisabeth GARANGER (Laboratoire de Chimie des Polymères Organiques)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

LCPO Laboratoire de Chimie des Polymères Organiques

Help of the ANR 202,645 euros
Beginning and duration of the scientific project: December 2015 - 36 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter